Global Transformer Oil Market Share Expected to Reach $3,159.0 Million by 2022: Zion Market Research
Oct 10, 2017 11:36 am UTC| Business
Sarasota, FL, Oct. 10, 2017 -- Zion Market Research has published a new report titled “Transformer Oil Market by Type (Mineral Oil-Based, Silicone-Based, and Bio-Based Oil), for Distribution Transformers and Power...
Yandex to Announce Third Quarter 2017 Financial Results on October 24th
Oct 10, 2017 11:30 am UTC| Business
MOSCOW and AMSTERDAM, The Netherlands, Oct. 10, 2017 -- Yandex (NASDAQ:YNDX) today announced it will report its financial results for the quarter ended September 30, 2017, on Tuesday, October 24, 2017. On that day,...
Depomed Provides Product Supply Information Following Hurricane Maria
Oct 10, 2017 11:30 am UTC| Business
NEWARK, Calif., Oct. 10, 2017 -- Depomed, Inc. (NASDAQ:DEPO) today provided information on the impact of Hurricane Maria to the supply of NUCYNTA® ER, which is manufactured in Puerto Rico by the Company’s third party...
Cloudbeds Acquires OneRooftop and Steps Up Their Vacation Rental Offerings
Oct 10, 2017 11:30 am UTC| Business
SAN DIEGO, Oct. 10, 2017 -- Cloudbeds, the leading provider of hospitality management software for independent properties (hotels, hostels, inns, bed and breakfasts, campgrounds, and more), today announced their...
Vemanti Group Signs Letter of Intent to Acquire Two Group of Vietnam
Oct 10, 2017 11:30 am UTC| Business
NEWPORT BEACH, Calif., Oct. 10, 2017 -- Vemanti Group, Inc. (OTC PINK:VMNT), a diversified holding corporation, today announces that it has entered into a Letter of Intent (LOI) to acquire 100% of assets from Two Group,...
Onconova Therapeutics to Present Updates at Two Investor Conferences in October
Oct 10, 2017 11:30 am UTC| Business
NEWTOWN, Pa., Oct. 10, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on...
Oct 10, 2017 11:30 am UTC| Business
MADISON, Wis. and CASTRES, France, Oct. 10, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company (the “company”), together with leading French pharmaceutical...